Please assess the completion status of the following clinical trial:

Trial Title: Calcium for Prevention of Ovarian Hyperstimulation Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* infertile women aged 20 to 38 years.~* BMI ranged from 18 to 40.~* serum FSH within normal limits( 1-12IU /l)~* presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.~Exclusion Criteria:~* endocrinopathies.~* a systemic disease.~* using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists.~* patients need coasting for high risk of OHSS.~* patients need cycle cancellation.~* severe male infertility requiring testicular sperm extraction.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- saline (Type: PLACEBO_COMPARATOR): 0.9% saline intravenous infusion
- calcium (Type: EXPERIMENTAL): Calcium intravenous infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).